Fuzhuo Li

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Ejection Fraction

Ulcerative Colitis

Radical Prostatectomy

Prostate Cancer

Top Venues

The Journal of experimental medicine

Beilstein journal of organic chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Senze Qiao, Zhongyu Cheng, Fuzhuo Li
Chemoenzymatic synthesis of macrocyclic peptides and polyketides via thioesterase-catalyzed macrocyclization. Beilstein journal of organic chemistry 20 (2024)
Senze Qiao, Zhongyu Cheng, Fuzhuo Li
Chemoenzymatic synthesis of macrocyclic peptides and polyketides via thioesterase-catalyzed macrocyclization. Beilstein journal of organic chemistry 20 (2024)
Ji-Hak Jeong, Shangwei Zhong, Fuzhuo Li, Changhao Huang, Xueyan Chen, Qingqing Liu, Shoujiao Peng, HaJeung Park, You Mie Lee, Jasreman Dhillon, Jun-Li Luo
Tumor-derived OBP2A promotes prostate cancer castration resistance. The Journal of experimental medicine 220 (3) (2022)
Ji-Hak Jeong, Shangwei Zhong, Fuzhuo Li, Changhao Huang, Xueyan Chen, Qingqing Liu, Shoujiao Peng, HaJeung Park, You Mie Lee, Jasreman Dhillon, Jun-Li Luo
Tumor-derived OBP2A promotes prostate cancer castration resistance. The Journal of experimental medicine 220 (3) (2022)
Ji-Hak Jeong, Shangwei Zhong, Fuzhuo Li, Changhao Huang, Xueyan Chen, Qingqing Liu, Shoujiao Peng, HaJeung Park, You Mie Lee, Jasreman Dhillon, Jun-Li Luo
Tumor-derived OBP2A promotes prostate cancer castration resistance. The Journal of experimental medicine 220 (3) (2022)
Ji-Hak Jeong, Shangwei Zhong, Fuzhuo Li, Changhao Huang, Xueyan Chen, Qingqing Liu, Shoujiao Peng, HaJeung Park, You Mie Lee, Jasreman Dhillon, Jun-Li Luo
Tumor-derived OBP2A promotes prostate cancer castration resistance. The Journal of experimental medicine 220 (3) (2022)
Ji-Hak Jeong, Shangwei Zhong, Fuzhuo Li, Changhao Huang, Xueyan Chen, Qingqing Liu, Shoujiao Peng, HaJeung Park, You Mie Lee, Jasreman Dhillon, Jun-Li Luo
Tumor-derived OBP2A promotes prostate cancer castration resistance. The Journal of experimental medicine 220 (3) (2022)